Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-005190
Filing Date
2022-02-22
Accepted
2022-02-22 11:35:16
Documents
1
Period of Report
2022-02-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6016
  Complete submission text file 0001567619-22-005190.txt   7661
Mailing Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003
Business Address 228 PARK AVENUE S. #66643 NEW YORK NY 10003 (516) 962-3186
Cambrian BioPharma Inc (Reporting) CIK: 0001797409 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 22656434

Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations